Press release
Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough
Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth [https://oxperial.co.uk/], revealed their major breakthrough in cancer prevention-a sunlight-powered technology that boosts the body's natural defenses against cancer.
His team's innovation, known as GPDT (Green Products Photodynamic Technology), uses plant-derived compounds activated by natural sunlight to trigger cellular responses that help eliminate abnormal or cancerous cells. The research, which specifically targets human brain cancer, was recently published in the international journal Future Science OA [https://www.tandfonline.com/doi/full/10.1080/20565623.2025.2464491#abstract].
Charging Cells Like Superman
Inspired by the idea of "charging cells like Superman," GPDT works by using light-sensitive plant compounds-mainly chlorophyll derivatives-that respond to sunlight in the visible spectrum (400-700 nm). Once activated, these compounds trigger a photodynamic response that boosts cellular energy and slows the growth of abnormal cells.
This chain reaction helps support the body's natural immune and energy systems at the cellular level. While the concept is grounded in nature, the delivery is highly targeted. GPDT has already been granted patents in the UK and Taiwan, with more pending internationally.
A Fusion of Nature and Innovation
Dr. Chen was joined by fellow researcher from Oxperial BioHealth, Allison Huang, RPh, who explained how the technology strengthens the body's innate energy systems and immunity. Co-authors Prof. Yao Kuan Chen and Dr. Jeff Liu added that light activation improves how plant-based compounds are absorbed and used by the body, increasing both their effectiveness and safety. According to the team, it's this fusion of natural ingredients and scientific precision that sets GPDT apart. The team believes GPDT holds strong potential, not only as a functional food supplement for preventive health, but also as a future novel therapy for cancer prevention and immune modulation.
Bridging Science, Industry, and Public Health
At the launch event in Taipei, Dr. Chen showcased GPDT's potential applications in cancer prevention and wellness. The event drew strong interest from leaders in Taiwan's biotech and healthcare sectors, many of whom expressed intent to collaborate on bringing this innovation to the public.
"This is more than just a scientific discovery," said Dr. Chen. "We're showing that natural compounds, activated by something as simple as sunlight, can create powerful effects in the fight against cancer. It's a leap forward in preventive medicine."
Meeting an Unmet Need in Holistic Cancer Care
Oxperial BioHealth is positioning itself at the forefront of a rapidly growing movement in integrative oncology, addressing the unmet demand for natural, non-invasive therapies that support conventional cancer treatments.
Many cancer patients today seek complementary approaches that enhance their quality of life, strengthen immunity, and reduce side effects associated with chemotherapy and radiation. However, the current supplement and wellness market often lacks options that are both scientifically validated and specifically designed for oncology support.
GPDT represents a timely response to this gap, offering a research-backed solution grounded in plant-based science and photodynamic principles. Oxperial's goal is to develop safe, effective, and rigorously tested supplements and preventive health solutions that align with patient preferences for holistic, evidence-based care. By combining biotechnology with nature's healing mechanisms, the company aims to empower individuals with choices that complement traditional medicine, supporting wellness before, during, and after treatment.
Media Contact
Company Name: Oxperial Biohealth
Contact Person: Daniel Chen
Email: Send Email [http://www.universalpressrelease.com/?pr=oxford-scientists-reveal-sunlightpowered-anticancer-breakthrough]
City: Oxford
Country: United Kingdom
Website: https://oxperial.co.uk/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough here
News-ID: 3976709 • Views: …
More Releases from Getnews
The U.S. Green Card: Turning a Temporary Stay into a Permanent American Future
Image: https://www.globalnewslines.com/uploads/2025/12/1766183100.jpg
For many people, a U.S. visa is only the beginning. What they truly want is certainty - the ability to live, work, and plan their future in the United States without expiry dates, renewals, or ongoing fear that a single decision could unravel years of effort.
That certainty is called a Green Card.
Yet despite its importance, the Green Card [https://larhdellaw.com/] process is often misunderstood. Some believe it is only for…
The L-1 Visa: How Global Businesses Expand to the U.S. Without Starting From Scr …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182907.jpg
For international companies with ambitions to enter the United States, few visa options are as powerful - or as misunderstood - as the L-1 Intracompany Transfer Visa.
When used correctly, the L-1 visa allows established businesses to expand into the U.S. market, transfer trusted senior staff, and build a long-term American presence without relying on lotteries, third-party sponsors, or speculative investment routes. When used incorrectly, it becomes one of the…
The B-1/B-2 Visitor Visa: Why Careful Preparation Matters More Than Ever
Image: https://www.globalnewslines.com/uploads/2025/12/1766182346.jpg
The B-1/B-2 visitor visa [https://larhdellaw.com/]is often described as the most common U.S. visa. That description, while true, can be misleading. Its familiarity causes many applicants to underestimate how closely these visas are scrutinised - and how easily an application can be refused.
In today's immigration environment, visitor visas are assessed with a level of caution that surprises even experienced international travellers. The rules themselves have not dramatically changed, but how…
The E-2 Visa Explained: How to Invest in the U.S. Without Buying a Green Card (a …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182716.jpg
For entrepreneurs, investors, and business owners looking to live and work in the United States, the E-2 Treaty Investor Visa remains one of the most attractive - and misunderstood - visa options available.
Every year, we speak with applicants who have invested significant money, launched businesses, or even hired staff, only to discover that their E-2 application was refused or delayed due to avoidable legal and strategic errors. The truth…
